Recurrent Cervical Cancer Clinical Trials
28 clinical trials for Recurrent Cervical Cancer across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer — RECRUITING
- PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer — RECRUITING · PHASE2
- A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer — RECRUITING · PHASE3
- Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy — RECRUITING
- First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer — TERMINATED · PHASE2
- Circulating cfDNA and HPV as Prognostic Biomarkers for First-Line Recurrent Metastatic Cervical Cancer — NOT_YET_RECRUITING
- Study of Anti-PD-1 Combined With Albumin-Bound Paclitaxel in Patients With Recurrent Cervical Cancer — COMPLETED · PHASE2
- Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer — COMPLETED · PHASE2
- QL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical Cancer — NOT_YET_RECRUITING
- The Efficacy and Safety RC48 Plus QL1706 in Second-Line Treatment of HER2-Expressing Recurrent CC — NOT_YET_RECRUITING · PHASE2
- A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer — COMPLETED · PHASE2
- Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer — TERMINATED · PHASE2
- Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers — COMPLETED · NA
- Genetic Mutation in Recurrent Cervical Cancer — OTHER
- Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer — COMPLETED · PHASE1
- Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix — COMPLETED · PHASE2
- Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer — COMPLETED · PHASE2
- Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors — COMPLETED · PHASE1
- Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer — COMPLETED · NA
- Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer — COMPLETED · PHASE1
- Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery — COMPLETED · PHASE2
- Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies — COMPLETED · PHASE2
- 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) — COMPLETED · PHASE1
- Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu — COMPLETED · PHASE1
- Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix — COMPLETED · PHASE2
- Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction — COMPLETED · PHASE1
- Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies — COMPLETED · PHASE1
- Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer — WITHDRAWN · NA
Refine this search